Is Cellectis Sa Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 4 Wall Street analysts covering (NASDAQ: CLLS) stock is to Hold CLLS stock.
Out of 4 analysts, 0 (0%) are recommending CLLS as a Strong Buy, 1 (25%) are recommending CLLS as a Buy, 2 (50%) are recommending CLLS as a Hold, 0 (0%) are recommending CLLS as a Sell, and 1 (25%) are recommending CLLS as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year CLLS price target, the average CLLS price target is $4.10, with the highest CLLS stock price forecast at $8.00 and the lowest CLLS stock price forecast at $1.30.
On average, Wall Street analysts predict that Cellectis Sa's share price could reach $4.10 by Sep 16, 2027. The average Cellectis Sa stock price prediction forecasts a potential upside of 314.14% from the current CLLS share price of $0.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.